UCB And 3 Other Stocks Have Very High Payout Ratio

(VIANEWS) – UCB (UCB.BR), TOMRA SYSTEMS (TOM.OL), AEGON (AGN.AS) are the highest payout ratio stocks on this list.

Here’s the data we’ve collected of stocks with a high payout ratio up to now. The payout ratio in itself isn’t a guarantee of a future good investment but it’s an indicator of whether dividends are being paid and how the company chooses to distribute them.

When researching a potential investment, the dividend payout ratio is a good statistic to know so here is a list of some companies with an above 30% payout ratio.

1. UCB (UCB.BR)

111.48% Payout Ratio

UCB SA, a biopharmaceutical company, develops products and solutions for people with neurology and immunology diseases worldwide. The company's primary products include Cimzia for inflammatory TNF mediated diseases, as well as ankylosing spondylitis, axial spondyloarthritis, Crohn's disease, non-radiographic axial spondyloarthritis, plaque psoriasis, psoriatic arthritis, and rheumatoid arthritis; Vimpat, Keppra, and Briviact for epilepsy; Neupro for Parkinson's disease and restless legs syndrome; Nayzilam, a nasal spray rescue treatment for epilepsy seizure clusters; and Zyrtec and Xyzal for allergies. It also offers Evenity for the treatment of osteoporosis in postmenopausal women; Bimzelx for treating plaque psoriasis, psoriatic arthritis, and axial spondyloarthritis; and Fintepla to treat Dravet syndrome. In addition, the company is involved in developing rozanolixizumab and Zilbrisq to treat myasthenia gravis; dapirolizumab pegol for systemic lupus erythematosus; fenfluramine to treat CDKL5 deficiency disorder; doxecitine for TK2 deficiency disorder; STACCATO alprazolam for stereotypical prolonged seizures; bepranemab to treat Alzheimer's disease; minzasolmin and UCB0222 for Parkinson's disease; and UCB1381 and UCB9741 for atropic dermatitis. Further, it engages in contract manufacturing activities. UCB SA has collaboration agreements with Amgen, Biogen, Roche/Genentech, Novartis, and Otsuka. The company was incorporated in 1925 and is headquartered in Brussels, Belgium.

Earnings Per Share

As for profitability, UCB has a trailing twelve months EPS of €1.22.

PE Ratio

UCB has a trailing twelve months price to earnings ratio of 136.11. Meaning, the purchaser of the share is investing €136.11 for every euro of annual earnings.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 2.67%.

Yearly Top and Bottom Value

UCB’s stock is valued at €166.05 at 22:10 EST, below its 52-week high of €169.35 and way above its 52-week low of €65.40.

Moving Average

UCB’s worth is higher than its 50-day moving average of €157.99 and way higher than its 200-day moving average of €123.54.

Revenue Growth

Year-on-year quarterly revenue growth grew by 10.8%, now sitting on 5.45B for the twelve trailing months.

More news about UCB.

2. TOMRA SYSTEMS (TOM.OL)

97.39% Payout Ratio

Tomra Systems ASA provides sensor-based solutions for optimal resource productivity worldwide. It operates through three segments: TOMRA Collection, TOMRA Recycling, and TOMRA Food. The TOMRA Collection segment engages in the development, production, sale, and service of reverse vending machines and related data management systems. This segment is also involved in picking up, transporting, and processing empty beverage containers on behalf of beverage producers/fillers. The TOMRA Recycling segment engages in the development, production, sale, and service of sorting and processing technology for waste management companies or plant builders. This segment offers sorting systems for waste and metal material streams; and ore sorting systems for mining companies. The TOMRA Food segment is involved in the development, production, sale, and service of sorting and processing technology, including sensor-based sorting solutions and integrated post-harvest solutions to detect and remove unwanted materials from manufacturing and processing lines for fresh and processed food industries. Tomra Systems ASA was founded in 1972 and is headquartered in Asker, Norway.

Earnings Per Share

As for profitability, TOMRA SYSTEMS has a trailing twelve months EPS of kr1.99.

PE Ratio

TOMRA SYSTEMS has a trailing twelve months price to earnings ratio of 76.13. Meaning, the purchaser of the share is investing kr76.13 for every norwegian krone of annual earnings.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 9.21%.

Sales Growth

TOMRA SYSTEMS’s sales growth is 15% for the present quarter and 3.8% for the next.

Yearly Top and Bottom Value

TOMRA SYSTEMS’s stock is valued at kr151.50 at 22:10 EST, way under its 52-week high of kr182.00 and way higher than its 52-week low of kr80.68.

Growth Estimates Quarters

The company’s growth estimates for the present quarter and the next is 125% and 213.3%, respectively.

More news about TOMRA SYSTEMS.

3. AEGON (AGN.AS)

66.67% Payout Ratio

Aegon Ltd. provides insurance, pensions, retirement, and asset management services in the United States, the Netherlands, the United Kingdom, and internationally. The company offers life, accident, property and casualty, and health insurance; annuities, retirement plans, mutual funds, and stable value solutions; residential mortgage and digital baking services; and retail and institutional investment management solutions and retirement savings vehicles and strategies. It offers its products under the Aegon and Transamerica brands. Aegon Ltd. was founded in 1844 and is headquartered in The Hague, the Netherlands.

Earnings Per Share

As for profitability, AEGON has a trailing twelve months EPS of €-0.07.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -1.38%.

More news about AEGON.

4. GLANBIA PLC (GL9.IR)

34.39% Payout Ratio

Glanbia plc, together with its subsidiaries, operates as a nutrition company worldwide. The company offers sports nutrition and lifestyle nutrition products in various formats, such as powders, ready-to-eat bars and snacking food, and ready-to-drink beverage. It also manufactures and sells cheese, dairy, and non-dairy nutritional and functional ingredients; and vitamin and mineral premixes products. In addition, the company engages in the financing; research and development; property and land dealing; holding and management of receivables; property leasing; business services; management solutions; weight management; flavor solutions; and bioactive solutions businesses. It offers its products under the Optimum Nutrition, BSN, Isopure, Nutramino, SlimFast, think!, Amazing Grass, Body & Fit, and LevlUp brands. The company sells its products through specialty retail, online, gym, and food, drug, mass, and club channels. Glanbia plc was founded in 1964 and is headquartered in Kilkenny, Ireland.

Earnings Per Share

As for profitability, GLANBIA PLC has a trailing twelve months EPS of €1.01.

PE Ratio

GLANBIA PLC has a trailing twelve months price to earnings ratio of 14.68. Meaning, the purchaser of the share is investing €14.68 for every euro of annual earnings.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 14.1%.

Moving Average

GLANBIA PLC’s worth is way under its 50-day moving average of €16.63 and way under its 200-day moving average of €17.13.

More news about GLANBIA PLC.

1. 1 (1)

1% Payout Ratio

1

Earnings Per Share

As for profitability, 1 has a trailing twelve months EPS of €1.

PE Ratio

1 has a trailing twelve months price to earnings ratio of 1. Meaning, the purchaser of the share is investing €1 for every euro of annual earnings.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 1%.

Growth Estimates Quarters

The company’s growth estimates for the present quarter and the next is 1% and 1%, respectively.

Volatility

1’s last week, last month’s, and last quarter’s current intraday variation average was 1.00%, 1.00%, and 1.00%.

1’s highest amplitude of average volatility was 1.00% (last week), 1.00% (last month), and 1.00% (last quarter).

More news about 1.

Leave a Reply

Your email address will not be published. Required fields are marked *